Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Resectable NSCLC × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 2243 Lung Neoplasms 1044 Small Cell Lung Carcinoma 396 Adenocarcinoma of Lung 154 Mesothelioma, Malignant 120 Breast Neoplasms 109 Neoplasms 106 Brain Neoplasms 100 Neoplasm Metastasis 95 Melanoma 72 Mesothelioma 69 NSCLC 67 Colorectal Neoplasms 67 Adenocarcinoma, Bronchiolo-Alveolar 56 Thymoma 53 Pancreatic Neoplasms 52 Head and Neck Neoplasms 46 Ovarian Neoplasms 45 Carcinoma, Renal Cell 42 Carcinoma 38 Stomach Neoplasms 36 Sarcoma 35 Prostatic Neoplasms 35 Esophageal Neoplasms 34 Adenocarcinoma 34 Squamous Cell Carcinoma of Head and Neck 33 Pleural Effusion, Malignant 33 Uterine Cervical Neoplasms 31 Recurrence 27 Carcinoma, Hepatocellular 27

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07492342 2026-03-25

K-NADIR

The First Affiliated Hospital of Guangzhou Medical University

Phase 2 Recruiting

Resectable NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡